The potential prognostic value of connexin 26 and 46 expression in neoadjuvant-treated breast cancer
Ivett Teleki(Semmelweis University), Zsuzsanna Varga(University of Zurich)
Cited by 54
Related Papers
How Reliable Is Ki-67 Immunohistochemistry in Grade 2 Breast Carcinomas? A QA Study of the Swiss Working Group of Breast- and Gynecopathologists
|PLoS ONE|2012|226
SARS-CoV-2 leads to a small vessel endotheliitis in the heart
|EBioMedicine|2021|121
Tubular and endothelial chimerism in renal allografts using fluorescence and chromogenic in situ hybridization (FISH, CISH) technology
|Pathology International|2012|14
Topoisomerase 2A gene amplification in breast cancer. Critical evaluation of different FISH probes
|Breast Cancer Research and Treatment|2011|13